Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study — Naoya Kato (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study
Shared by
Masatoshi Kudo
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study
Article
2023
en
Authors
+11 more
NK
Naoya Kato
Masatoshi Kudo
KT
Kaoru Tsuchiya
Abstract
1 min read
Cabozantinib showed efficacy and a manageable safety profile in Japanese patients with advanced HCC.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study
Masatoshi Kudo
,
Kaoru Tsuchiya
,
Naoya Kato
,
Atsushi Hagihara
,
Kazushi Numata
,
Hiroshi Aikata
,
Yoshitaka Inaba
,
Shunsuke Kondo
,
Kenta Motomura
,
Junji Furuse
,
Masafumi Ikeda
,
Manabu Morimoto
,
Meguru Achira
,
Shingo Kuroda
,
Akiko Kimura
Article
2020
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort
Toshihiko Doi
,
Yutaka Fujiwara
,
Takafumi Koyama
,
Masafumi Ikeda
,
Christoph Helwig
,
Morihiro Watanabe
,
Yulia Vugmeyster
,
Masatoshi Kudo
Article
2021
Cabozantinib: An evolving therapy for hepatocellular carcinoma
Anthony B. El-Khoueiry
,
Diana L. Hanna
,
Josep M. Llovet
,
Robin Kate Kelley
Cancer Treatment Reviews
Article
2020
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial
Masatoshi Kudo
,
Takuji Okusaka
,
Kenta Motomura
,
Izumi Ohno
,
Manabu Morimoto
,
Satoru Seo
,
Yoshiyuki Wada
,
Shinpei Sato
,
Tatsuya Yamashita
,
Masayuki Furukawa
,
Takeshi Aramaki
,
Seijin Nadano
,
Kazuyoshi Ohkawa
,
Hirofumi Fujii
,
Toshihiro Kudo
,
Junji Furuse
,
Hiroki Takai
,
Gosuke Homma
,
Reigetsu Yoshikawa
,
Andrew X. Zhu
Dataset
Supplementary Material for: Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial
Masatoshi Kudo
,
Kenta Motomura
,
Yoshiyuki Wada
,
Yoshitaka Inaba
,
Yasunari Sakamoto
,
Masayuki Kurosaki
,
Yoshiko Umeyama
,
Yoichi Kamei
,
J. Yoshimitsu
,
Yoshiro Fujii
,
Mamoru Aizawa
,
Paul B. Robbins
,
Junji Furuse
Discussion(0)
No comments yet. Be the first to comment.